Cargando…
大剂量甲泼尼龙联合利妥昔单抗及新鲜冰冻血浆治疗伴有TP53基因异常的B细胞慢性淋巴增殖性疾病六例
OBJECTIVE: To investigate whether high-dose methylprednisolone with Rituximab and fresh frozen plasma (HDMP+RTX+FFP) is an effective therapy for patients with B-cell chronic lymphoproliferative disorders (B-CLPD) with TP53 abnormalities. METHODS: Six B-CLPD patients with TP53 abnormalities from May...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342232/ https://www.ncbi.nlm.nih.gov/pubmed/31207703 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.05.008 |
Ejemplares similares
-
改良利妥昔单抗联合新鲜冰冻血浆及甲泼尼龙方案治疗九例以血小板减少为主要表现的慢性淋巴细胞白血病临床疗效分析
Publicado: (2019) -
凝血酶原复合物联合小剂量利妥昔单抗治疗血友病B伴抑制物
Publicado: (2017) -
剂量调整的EP(D)OCH方案联合利妥昔单抗治疗新诊断双表达淋巴瘤的疗效分析
Publicado: (2017) -
小剂量利妥昔单抗治疗12例难治/复发原发性自身免疫性溶血性贫血患者疗效分析
Publicado: (2017) -
大剂量地塞米松联合小剂量利妥昔单抗作为二线方案治疗65例原发免疫性血小板减少症患者的临床观察
Publicado: (2015)